Potential ASCO Practice-Changers in HER2+ Breast Cancer Potential ASCO Practice-Changers in HER2+ Breast Cancer

Oncologists will debate the APHINITY trial data for years to come, says Dr Kevin Kalinsky.Medscape Oncology

Source: Medscape Today Headlines - July 7, 2017 Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news